Home
>
National Drug Code (NDC)
>
DIDANOSINE
DIDANOSINE - 68084-431-21 - (DIDANOSINE)
Drug Information of DIDANOSINE
| Product NDC: | 68084-431 |
| Proprietary Name: | DIDANOSINE |
| Non Proprietary Name: | DIDANOSINE |
| Active Ingredient(s): | 250 mg/1 & nbsp; DIDANOSINE |
| Administration Route(s): | ORAL |
| Dosage Form(s): | CAPSULE, DELAYED RELEASE |
| Coding System: | National Drug Codes(NDC) |
Labeler Information of DIDANOSINE
| Product NDC: | 68084-431 |
| Labeler Name: | American Health Packaging |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | ANDA077167 |
| Marketing Category: | ANDA |
| Start Marketing Date: | 20091208 |
Package Information of DIDANOSINE
| Package NDC: | 68084-431-21 |
| Package Description: | 3 BLISTER PACK in 1 CARTON (68084-431-21) > 10 CAPSULE, DELAYED RELEASE in 1 BLISTER PACK (68084-431-11) |
NDC Information of DIDANOSINE
| NDC Code | 68084-431-21 |
| Proprietary Name | DIDANOSINE |
| Package Description | 3 BLISTER PACK in 1 CARTON (68084-431-21) > 10 CAPSULE, DELAYED RELEASE in 1 BLISTER PACK (68084-431-11) |
| Product NDC | 68084-431 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | DIDANOSINE |
| Dosage Form Name | CAPSULE, DELAYED RELEASE |
| Route Name | ORAL |
| Start Marketing Date | 20091208 |
| Marketing Category Name | ANDA |
| Labeler Name | American Health Packaging |
| Substance Name | DIDANOSINE |
| Strength Number | 250 |
| Strength Unit | mg/1 |
| Pharmaceutical Classes | Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC],Nucleoside Analog [Chemical/Ingredient],Nucleoside Reverse Transcriptase Inhibitors [MoA] |
